Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Early repayment doesn’t necessarily save interest costs. OnDeck is an online lender ... which can range from 1.037 to 1.45 for term loans and 1.10 to 1.30 for lines of credit.

Vizient released its new Spend Management Outlook representing a comprehensive analysis of emerging trends and pricing dynamics affecting healthcare.